Tag: AC Immune

December 12, 2019

Biotech Trends 2019: M&A Slows, CNS Therapies Make Headlines

2019 marked another critical year of growth for the biotech market. Learn about key biotech trends before the new year...
September 12, 2019

5 Alzheimer’s Disease Treatment Stocks on the NASDAQ

A report from Reports and Data suggests the overall Alzheimer's market will be worth US$12.43 billion by 2026.
November 13, 2018

AC Immune Reports Third Quarter 2018 Financial Results and Corporate Update

AC Immune (NASDAQ:ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, announced financial results for...
April 5, 2018

AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer’s disease

AC Immune (NASDAQ:ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that...
March 20, 2018

AC Immune reports full-year 2017 financial results

AC Immune (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced...
October 26, 2017

The State of Novel Alzheimer's Treatments

Alzheimer's already affects nearly five million Americans, with a growing population incoming, the need for an improved treatment is a...
September 23, 2016

AC Immune Opens For Trading On NASDAQ

AC Immune, a Swiss-based, clinical stage biopharmaceutical company focused on neurodegenerative diseases, today announced that its common shares will open...